Xuan Li

Title: Xuan Li: Innovator in Anti-Tumor Polypeptides

Introduction

Xuan Li is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of biotechnology, particularly in the development of anti-tumor drugs. His innovative work focuses on polypeptides that have the potential to combat cancer effectively.

Latest Patents

Xuan Li holds a patent for "Anti-tumor polypeptides and method for preparing anti-tumor drugs comprising the same." This patent includes an anti-tumor polypeptide with an amino acid sequence represented by FPGSDRF (SEQ ID NO: 15), X-FPGSDRF (SEQ ID NO: 16), FPGSDRF-Z (SEQ ID NO: 17), or X-FPGSDRF-Z (SEQ ID NO: 18). The sequences involve various amino acids, including phenylalanine, proline, glycine, aspartic acid, arginine, and phosphorylated serine residues. The patent outlines the potential of these polypeptides in the preparation of effective anti-tumor drugs.

Career Highlights

Xuan Li has worked at Nanjing Medical University, where he has contributed to research and development in the medical field. His expertise in biotechnology has positioned him as a valuable asset in the fight against cancer. He has also collaborated with notable professionals in his field, enhancing the impact of his work.

Collaborations

Xuan Li has worked alongside colleagues such as Jianwei Zhou and Jin Xu. Their collaborative efforts have furthered research in anti-tumor therapies and have led to advancements in the understanding of polypeptide applications in medicine.

Conclusion

Xuan Li's innovative contributions to the field of anti-tumor polypeptides highlight his dedication to advancing medical science. His patent and collaborative work demonstrate the potential for significant breakthroughs in cancer treatment.